Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Clinical Antipsychotic Trials CATIE

Lieberman JA, Stroup TS, McEvoy JP, et al. Clinical antipsychotic trials of intervention effectiveness (CATIE) investigators. Effectiveness of antipsychotic drugs in people with chronic schizophrenia. N Engl J Med 2005 353 1209-1223. [Pg.567]

The African-American Heart Failure Trial showed that a large number of African Americans can be recruited in sufficient numbers with enough power to show efficacy in a clinical trial. In psychiatry the large START) study of depression was made up of 24% minorities (Trivedi etal, 2006). The recently completed Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) was able to recruit enough African Americans to make up about one third of its participants (Stroup et al, 2006). [Pg.115]

CATIE Clinical antipsychotic trial of intervention effectiveness... [Pg.289]

CLINICAL ANTIPSYCHOTIC TRIALS OF INTERVENTION EFFECTIVENESS (CATIE)... [Pg.29]

The CATIE project will evaluate the clinical effectiveness of atypical antipsychotics in the treatment of schizophrenia and of Alzheimer s disease. Although antipsychotics were first introduced for the treatment of schizophrenia, they are now used for many other disorders. It is unclear how effective they are and, most important, in view of their rather high cost, how favorably they compare to the first generation of antipsychotics, all of which are available in generic (and thus much less expensive) forms. The CATIE (Clinical Antipsychotic Trials in Intervention Effectiveness) study has specific aims, including the determination of long-term effectiveness and tolerability of the atypical antipsychotics, compared to each and to a typical or classic antipsychotic. At this... [Pg.268]

McEvoy JP, Meyer JM, Goff DC, et al. Prevalence of the metabolic syndrome in patients with schizophrenia baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005 80 19-32. [Pg.131]

Changes in the 10-year risk of coronary heart disease have been compared between treatment groups in 1125 patients followed for 18 months or until treatment discontinuation in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) in schizophrenia [22 ]. The mean change in 10-year coronary heart disease risk differed significantly between treatments. Olanzapine was associated with a 0.5% increase and quetiapine with a 0.3% increase, while the risk fell in patients who used perphenazine (-0.5%), risperidone (—0.6%), and ziprasidone (—0.6%). The difference in 10-year coronary heart disease risk between olanzapine and risperidone was statistically significant. [Pg.94]

Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Riggio S, Chakos MH, Swartz MS, Keefe RS, Stroup TS, Lieberman JA. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Extrapyramidal side-effects of antipsychotics in a randomised trial. Br J Psychiatry 2008 193(4) 279 8. [Pg.117]

Nasrallah, H. (2007). The roles of efficacy, safety, and tolerability in antipsychotic effectiveness Practical implications of the CATIE schizophrenia trial. Journal of Clinical... [Pg.507]

Weiden, P. (2007a). Discontinuing and switching antipsychotic medications Understanding the CATIE schizophrenia trial. Journal of Clinical Psychiatry, 68 (Suppl. 1), 12—19. [Pg.523]


See other pages where Clinical Antipsychotic Trials CATIE is mentioned: [Pg.102]    [Pg.83]    [Pg.24]    [Pg.568]    [Pg.127]   
See also in sourсe #XX -- [ Pg.24 , Pg.29 , Pg.30 , Pg.31 , Pg.52 ]




SEARCH



CATIE

Clinical Antipsychotic Trials

© 2024 chempedia.info